½ÃÀ庸°í¼­
»óǰÄÚµå
1274494

¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå º¸°í¼­(2023³â)

Pet Healthcare Global Market Report 2023

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Business Research Company | ÆäÀÌÁö Á¤º¸: ¿µ¹® 250 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄɾî(Pet Healthcare) ½ÃÀåÀº 2022³â 2,139¾ï ´Þ·¯¿¡¼­ 2023³â 2,278¾ï 3,000¸¸ ´Þ·¯·Î CAGR 6.5%À» ±â·ÏÇÏ¸ç ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ÀüÀïÀº Àû¾îµµ ´Ü±âÀûÀ¸·Î COVID-19 ÆÒµ¥¹ÍÀÇ ¼¼°è °æÁ¦ ȸº¹ÀÇ °¡´É¼ºÀ» È¥¶õ½ÃÄ×½À´Ï´Ù. ÀÌ µÎ ±¹°¡ °£ÀÇ ÀüÀïÀº ¿©·¯ ±¹°¡¿¡ ´ëÇÑ °æÁ¦ Á¦Àç, »óǰ °¡°Ý »ó½Â, °ø±Þ¸Á È¥¶õÀ¸·Î À̾îÁ³À¸¸ç, »óǰ°ú ¼­ºñ½º Àü¹Ý¿¡ ÀÎÇ÷¹À̼ÇÀ» ÀÏÀ¸ÄÑ Àü¼¼°è ¸¹Àº ½ÃÀå¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀåÀº 2027³â CAGR 6.5%·Î 2,926¾ï 4,000¸¸ ´Þ·¯¸¦ ±â·ÏÇÏ¸ç ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

2022³â ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå¿¡¼­ ºÏ¹Ì°¡ ÃÖ´ë Áö¿ªÀ̾ú½À´Ï´Ù. ¾Æ½Ã¾Æ ÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÏ´Â Áö¿ªÀÌ µÉ Àü¸ÁÀÔ´Ï´Ù. ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå º¸°í¼­ÀÇ ´ë»ó Áö¿ªÀº ¾Æ½Ã¾Æ ÅÂÆò¾ç, ¼­À¯·´, µ¿À¯·´, ºÏ¹Ì, ³²¹Ì, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÔ´Ï´Ù.

µ¿¹°¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå ¼ºÀåÀ» ¾Õ´ç±æ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. µ¿¹°¼º ÁúȯÀº ÁÖ·Î µ¿¹°ÀÌ °¨¿°µÇ¸ç, °Ç°­ »óŸ¦ ¼Õ»ó½ÃŰ´Â Áúº´ÀÔ´Ï´Ù. ÀϺδ µ¿¹°¿¡°Ô Ä¡¸íÀûÀÎ Áúº´ÀÌ Àֱ⠶§¹®¿¡ ÀûÀýÇÑ Ä¡·á°¡ ÇÊ¿äÇÕ´Ï´Ù. ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î °ü¸®´Â Áúº´ ¿¹¹æ ¹× ÁøÇà Áß °¨¿°ÀÇ Ä¡·á¿¡ ¸Å¿ì È¿°úÀûÀÔ´Ï´Ù. ¿¹¸¦ µé¾î ¹Ì±¹À» °ÅÁ¡À¸·Î ÇÏ´Â ¾Ö¿Ïµ¿¹°º´¿ø 'BluePearl Pet Hospital'ÀÌ ¹ßÇ¥ÇÑ '2021 Pet Health Trends Report'¿¡ µû¸£¸é 2021³â¿¡´Â 85¸¸¸¶¸®ÀÇ ¾Ö¿Ïµ¿¹°ÀÌ º´¿ø¿¡¼­ Ä¡·á¸¦ ¹Þ°í 129¸¸¸¶¸®ÀÇ ¾Ö¿Ïµ¿¹°ÀÌ ³»¿øÇß´Ù°í ÇÕ´Ï´Ù. ÀÌ´Â 2020³â¿¡ ºñÇØ 2.3% Áõ°¡ÇÑ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±× °á°ú µ¿¹°ÀÇ °¨¿°ÀÌ Áõ°¡Çϰí ÀÖ´Ù´Â °ÍÀº ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀåÀ» ÀüÁø½Ã۰í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå Æ¯Â¡

Á¦3Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå µ¿Çâ ¹× Àü·«

Á¦4Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå-°Å½Ã °æÁ¦ ½Ã³ª¸®¿À

  • COVID-19°¡ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ·¯½Ã¾Æ-¿ìÅ©¶óÀ̳ª ÀüÀïÀÌ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • ³ôÀº ÀÎÇ÷¹À̼ÇÀÌ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâ

Á¦5Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå ±Ô¸ð ¹× ¼ºÀå

  • ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå ½ÇÀû(2017-2022³â)
    • ½ÃÀåÀÇ ÃËÁø ¿äÀÎ
    • ½ÃÀåÀÇ ¾ïÁ¦ ¿äÀÎ
  • ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå ¿¹Ãø(2022-2027³â, 2032³â)
    • ½ÃÀåÀÇ ÃËÁø ¿äÀÎ
    • ½ÃÀåÀÇ ¾ïÁ¦ ¿äÀÎ

Á¦6Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå ¼¼ºÐÈ­

  • ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • Ä¡·á
  • Áø´Ü
  • ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, µ¿¹° À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • °³°ú
  • °í¾çÀ̰ú
  • ¸»
  • Á¶·ù
  • ±âŸ µ¿¹°
  • ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ¼Ò¸Å
  • ÀüÀÚ»ó°Å·¡
  • º´¿ø ¾à±¹

Á¦7Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå-Áö¿ª ¹× ±¹°¡º° ºÐ¼®

  • ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, Áö¿ªº°, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ¼¼°èÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, ±¹°¡º°, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦8Àå ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î °ü¸® ½ÃÀå °³¿ä
  • Áö¿ª Á¤º¸, COVID-19ÀÇ ¿µÇâ, ½ÃÀå Á¤º¸, ¹è°æ Á¤º¸, Á¤ºÎÀÇ ´ëó, ±ÔÁ¦, ±ÔÁ¦ ±â°ü, ÁÖ¿ä ´Üü, °ú¼¼¾×, ¹ýÀμ¼ ±¸Á¶, ÅõÀÚ, ÁÖ¿ä ±â¾÷
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ¾Æ½Ã¾Æ ÅÂÆò¾çÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦9Àå Áß±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • Áß±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå °³¿ä
  • Áß±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • Áß±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦10Àå ÀεµÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ÀεµÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ÀεµÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦11Àå ÀϺ»ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ÀϺ»ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ÀϺ»ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦12Àå È£ÁÖÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • È£ÁÖÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • È£ÁÖÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦13Àå Àεµ³×½Ã¾ÆÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • Àεµ³×½Ã¾ÆÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • Àεµ³×½Ã¾ÆÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦14Àå Çѱ¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • Çѱ¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • Çѱ¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦15Àå ¼­À¯·´ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ¼­À¯·´ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î °ü¸® ½ÃÀå °³¿ä
  • ¼­À¯·´ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ¼­À¯·´ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦16Àå ¿µ±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ¿µ±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ¿µ±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦17Àå µ¶ÀÏÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • µ¶ÀÏÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • µ¶ÀÏÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦18Àå ÇÁ¶û½ºÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ÇÁ¶û½ºÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ÇÁ¶û½ºÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦19Àå µ¿À¯·´ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • µ¿À¯·´ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î °ü¸® ½ÃÀå °³¿ä
  • µ¿À¯·´ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • µ¿À¯·´ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦20Àå ·¯½Ã¾ÆÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ·¯½Ã¾ÆÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ·¯½Ã¾ÆÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦21Àå ºÏ¹ÌÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ºÏ¹ÌÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå °³¿ä
  • ºÏ¹ÌÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ºÏ¹ÌÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦22Àå ¹Ì±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ¹Ì±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå °³¿ä
  • ¹Ì±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ¹Ì±¹ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦23Àå ³²¹ÌÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ³²¹ÌÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå °³¿ä
  • ³²¹ÌÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ³²¹ÌÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦24Àå ºê¶óÁúÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ºê¶óÁúÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ºê¶óÁúÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦25Àå Áßµ¿ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • Áßµ¿ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå °³¿ä
  • Áßµ¿ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • Áßµ¿ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦26Àå ¾ÆÇÁ¸®Ä«ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå

  • ¾ÆÇÁ¸®Ä«ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î °ü¸® ½ÃÀå °³¿ä
  • ¾ÆÇÁ¸®Ä«ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Çüº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)
  • ¾ÆÇÁ¸®Ä«ÀÇ ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå, À¯Åë ä³Îº° ¼¼ºÐÈ­, ½ÇÀû ¹× ¿¹Ãø(2017-2022³â, 2022-2027³â, 2032³â)

Á¦27Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå-°æÀï »óȲ ¹× ±â¾÷ °³¿ä

  • ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå-°æÀï »óȲ
  • ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå-±â¾÷ °³¿ä
    • Ceva Sante Animale
    • Merck &Co. Inc.
    • Vetoquinol SA
    • Zoetis Inc.
    • Elanco Animal Health Incorporated

Á¦28Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå-ÁÖ¿ä ÇÕº´ ¹× Àμö

Á¦29Àå ¾Ö¿Ïµ¿¹° ÇコÄÉ¾î ½ÃÀå-ÇâÈÄ Àü¸Á ¹× ÀáÀç·Â ºÐ¼®

Á¦30Àå ºÎ·Ï

LYJ 23.05.24

“Pet Healthcare Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on pet healthcare market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pet healthcare? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The pet healthcare market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Therapeutics; Diagnostics
  • 2) By Animal Type: Canine; Feline; Equine; Avian; Other Animals
  • 3) By Distribution Channel: Retail; E-commerce; Hospital Pharmacies
  • Companies Mentioned: Ceva Sante Animale; Merck & Co. Inc.; Vetoquinol S.A.; Zoetis Inc.; Elanco Animal Health Incorporated
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the pet healthcare market are Ceva Sante Animale, Merck & Co. Inc., Vetoquinol S.A., Zoetis Inc., Elanco Animal Health Incorporated, Bayer Animal Health GmbH, Indian Immunologicals Limited, Bioniche Animal Health Canada Inc., Sanofi Animal Health Inc., Biogenesis Bago SA, Heska Corporation, Phibro Animal Health Corporation, IDEXX Laboratories Inc., Agrolabo SpA, Norbrook Laboratories Ltd., Novartis Animal Health US Inc., and Perrigo Company PLC.

The global pet healthcare market is expected to grow from $213.90 billion in 2022 to $227.83 billion in 2023 at a compound annual growth rate (CAGR) of 6.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The pet healthcare market is expected to grow to $292.64 billion in 2027 at a CAGR of 6.5%.

The pet healthcare market consists of sales of pet healthcare diagnostic tools, medicines and preventive care products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Pet healthcare refers to an approach in which preventive and therapeutic care is taken to keep the pet animal disease-free. It is useful for a healthy pet lifestyle. It entails a multifaceted strategy that includes a vet's assessment of the pet's general health and potential for illness or other health issues.

North America was the largest region in the pet healthcare market in 2022. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pet healthcare market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The major types of pet healthcare are therapeutics and diagnostics. Therapeutics refers to products such as vaccines, anti-parasitic products, and feed additives. Therapeutics are used for treating already-infected pets. It is used to cure various types of animals, such as canines, felines, equines, avian pets, and others. They are sold through various distribution channels, such as retail, e-commerce, and hospital pharmacies.

The rising prevalence of animal diseases is expected to propel the growth of the pet healthcare market forward. Animal diseases are diseases that mostly affect animals and impair their healthy state. Some of the diseases can be fatal for the animals, hence, they need proper treatment. Pet healthcare can be very useful for preventing diseases and treating ongoing infections. For instance, in 2021, according to the 2021 Pet Health Trends Report published by BluePearl Pet Hospital, a US-based pet hospital, 850,000 pets were treated in the hospital in 2021, accounting for 1.29 million pet visits. This is a 2.3% increase as compared to 2020. As a result, the increasing prevalence of animal infections is driving the pet healthcare market forward.

The advancement of diagnostic imaging techniques is a key trend gaining popularity in the pet healthcare market. Major companies operating in the pet healthcare market are introducing innovative diagnostic products to sustain their position in the market. For instance, in September 2020, Zoetis Inc., a US-based producer of medicine and vaccinations for pets and livestock, launched the Vetscan Imagyst, a new diagnostic platform for animal diagnostics. The new platform leverages image recognition technology, algorithms, and cloud-based artificial intelligence to deliver accurate testing results to the clinic. Vetscan Imagyst is an AI-powered deep learning platform that transforms in-clinic fecal testing at the time of the visit by enabling veterinarians to rapidly and effectively diagnose patients and administer treatment as necessary. Vetscan Imagyst is the most recent ground-breaking platform to be added to Zoetis Diagnostics' portfolio.

In July 2020, Zoetis, a US-based animal drug and vaccine manufacturer, acquired Fish Vet Group for $17.22 million (£14 million). The acquisition is a strategic addition to Zoetis' Pharmaq business developing fish vaccines and aquaculture diagnostics. Fish Vet Group is a Scotland-based provider of veterinary services and diagnostic technologies.

The countries covered in the pet healthcare market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The pet healthcare market research report is one of a series of new reports from The Business Research Company that provides pet healthcare market statistics, including pet healthcare industry global market size, regional shares, competitors with a pet healthcare market share, detailed pet healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the pet healthcare industry. This pet healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Pet Healthcare Market Characteristics

3. Pet Healthcare Market Trends And Strategies

4. Pet Healthcare Market - Macro Economic Scenario

  • 4.1. COVID-19 Impact On Pet Healthcare Market
  • 4.2. Ukraine-Russia War Impact On Pet Healthcare Market
  • 4.3. Impact Of High Inflation On Pet Healthcare Market

5. Pet Healthcare Market Size And Growth

  • 5.1. Global Pet Healthcare Historic Market, 2017-2022, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Pet Healthcare Forecast Market, 2022-2027F, 2032F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Pet Healthcare Market Segmentation

  • 6.1. Global Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Therapeutics
  • Diagnostics
  • 6.2. Global Pet Healthcare Market, Segmentation By Animal Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Canine
  • Feline
  • Equine
  • Avian
  • Other Animals
  • 6.3. Global Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Retail
  • E-Commerce
  • Hospital Pharmacies

7. Pet Healthcare Market Regional And Country Analysis

  • 7.1. Global Pet Healthcare Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 7.2. Global Pet Healthcare Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Pet Healthcare Market

  • 8.1. Asia-Pacific Pet Healthcare Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 8.3. Asia-Pacific Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Pet Healthcare Market

  • 9.1. China Pet Healthcare Market Overview
  • 9.2. China Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
  • 9.3. China Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Pet Healthcare Market

  • 10.1. India Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 10.2. India Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Pet Healthcare Market

  • 11.1. Japan Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 11.2. Japan Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Pet Healthcare Market

  • 12.1. Australia Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 12.2. Australia Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Pet Healthcare Market

  • 13.1. Indonesia Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 13.2. Indonesia Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Pet Healthcare Market

  • 14.1. South Korea Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 14.2. South Korea Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Pet Healthcare Market

  • 15.1. Western Europe Pet Healthcare Market Overview
  • 15.2. Western Europe Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 15.3. Western Europe Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Pet Healthcare Market

  • 16.1. UK Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 16.2. UK Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Pet Healthcare Market

  • 17.1. Germany Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 17.2. Germany Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Pet Healthcare Market

  • 18.1. France Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 18.2. France Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Pet Healthcare Market

  • 19.1. Eastern Europe Pet Healthcare Market Overview
  • 19.2. Eastern Europe Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 19.3. Eastern Europe Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Pet Healthcare Market

  • 20.1. Russia Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 20.2. Russia Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Pet Healthcare Market

  • 21.1. North America Pet Healthcare Market Overview
  • 21.2. North America Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 21.3. North America Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Pet Healthcare Market

  • 22.1. USA Pet Healthcare Market Overview
  • 22.2. USA Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 22.3. USA Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Pet Healthcare Market

  • 23.1. South America Pet Healthcare Market Overview
  • 23.2. South America Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 23.3. South America Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Pet Healthcare Market

  • 24.1. Brazil Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 24.2. Brazil Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Pet Healthcare Market

  • 25.1. Middle East Pet Healthcare Market Overview
  • 25.2. Middle East Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 25.3. Middle East Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Pet Healthcare Market

  • 26.1. Africa Pet Healthcare Market Overview
  • 26.2. Africa Pet Healthcare Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • 26.3. Africa Pet Healthcare Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Pet Healthcare Market Competitive Landscape And Company Profiles

  • 27.1. Pet Healthcare Market Competitive Landscape
  • 27.2. Pet Healthcare Market Company Profiles
    • 27.2.1. Ceva Sante Animale
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Merck & Co. Inc.
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Vetoquinol S.A.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Zoetis Inc.
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Elanco Animal Health Incorporated
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Pet Healthcare Market

29. Pet Healthcare Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Historic And Forecast Inflation Rates
  • 30.4. Research Inquiries
  • 30.5. The Business Research Company
  • 30.6. Copyright And Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦